Harvard 31st Annual Update in Neurology 2023

Harvard 31st Annual Update in Neurology 2023

Regular price€50,00
/
Tax included. Shipping calculated at checkout.

  • Free Shipping on orders over 45$
  • In stock, ready to ship
  • Inventory on the way

Harvard 31st Annual Update in Neurology 2023

Harvard 31st Annual Update in Neurology 2023 (Videos) This program provides a comprehensive, evidence-based review of state-of-the-art practices for outpatient and inpatient neurology. Education covers the latest guidelines, clinical strategies, and recent advances, including the use of genetic tests, optimal use of imaging, new approaches for diagnosis, and expanded options for treatment for a wide array of neurological diseases.

  • #Harvard 31st Annual Update in #Neurology 2023 (Videos)

  • Format : 70 Videos + PDFs

    File Size : 31.54 GB

    • Education is practical and focused on patient outcomes. Led by the foremost authorities in neurology subspecialties, the program provides tools to improve your care of patients with common, complex, and rare neurological conditions. As updates are presented, they are paired with specific practice recommendations to help you optimize patient care and outcomes.

    Who Should Attend

    • Physicians
    • Physician Assistants
    • Nurses
    • Nurse Practitioners

    Learning Objectives

    Upon completion of this activity, participants will be able to:

    • Apply updated research and guidelines for common neurological conditions in their care of patients.
    • Explain the principles of delivering neurological care in resource constrained environments.
    • Recognize immune mediated neurological diseases and initiate appropriate therapy.
    • Identify the most common causes of cognitive error in the diagnosis and treatment of neurological diseases.
    • Define types of seizures and mimickers of seizures.
    • Recognize and treat common and uncommon headache disorders and dizziness.
    • Summarize how to effectively prevent and manage stroke.
    • Develop strategies for diagnosing and treating complicated neurologic problems in the outpatient and inpatient settings.
      Program :

     

    Monday, October 9, 2023

    DAY ONE

    Introduction

    • Updates in Alzheimer's Disease
      Dennis J. Selkoe, MD
    • Q&A
    • State-of-the Art Approaches to the Diagnosis of Dementia
      Scott M. McGinnis, MD
    • Q&A
    • State-of-the-Art Approaches in the Treatment of Dementia
      Seth A. Gale, MD
    • Q&A
    • State-of-the-Art Diagnosis of Demyelinating Disease, MS, NMOSD, and MOGAD
      Tanuja Chitnis, MD
    • Q&A
    • Coma and Disorders of Consciousness*
      Martin A. Samuels, MD
    • Q&A
    • Updates in the Diagnosis and Medical Management of Parkinsonism
      Albert Y. Hung, MD, PhD
    • Q&A
    • Non-Pharmacologic Therapy of Movement Disorders
      Michael T. Hayes, MD
    • Q&A
    • Advances in Our Understanding of Hyperkinetic Movements
      Edison K. Miyawaki, MD
    • Q&A with Course Directors
      Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD

    Tuesday, October 10, 2023

    DAY TWO

    • Concussion and Sports-related Neurological Injuries: Guidance to Improve Patient Outcomes
      Claus Reinsberger, MD
    • Q&A
    • ‘Visual Disturbances
      Sashank Prasad, MD
    • Q&A
    • State-of-the-Art Approaches in Stroke Prevention and Treatment Prevention and Treatment
      Mariel G. Kozberg, MD, PhD
    • Q&A
    • Updates in Genetics of Cerebrovascular Disease
      Patricia L. Musolino, MD, PhD
    • Q&A
    • Current Approach to Myopathies
      Vijay S. Ganesh, MD, PhD
    • Q&A
    • Keynote: How Neurologists Think: What My Errors Taught Me*
      Martin A. Samuels, MD
    • Q&A
    • Neurologic Emergencies: Quick Identification and Steps to Optimize Patient Outcomes
      Bradley J. Molyneaux, MD, PhD
    • Q&A
    • Brain Tumors in 2023: State-of-the-Art and Emerging Treatment Options
      Tracy T. Batchelor, MD, MPH
    • Q&A with Course Directors
      Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD

    Wednesday, October 11, 2023

    DAY THREE

    • Best Practices for Diagnosing and Managing Psychogenic Non-Epileptic Seizures
      Barbara A. Dworetzky, MD
    • Q&A
    • Challenging Epilepsy Cases in Pregnancy
      Paula Emanuela Voinescu, MD
    • Q&A
    • Updates in Pharmacological Treatment of Epilepsy
      Jong Woo Lee, MD, PhD
    • Q&A
    • New Concepts in Non-Pharmacologic Treatment of Epilepsy
      Ellen J. Bubrick, MD
    • Q&A
    • Studying Functional Networks and Targeting Stimulation Treatment of Neuropsychiatric Diseases
      Michael D. Fox, MD, PhD
    • Q&A
    • Neurogenetics and Impact on Clinical Practice
      Scott R. Plotkin, MD, PhD
    • Q&A
    • Below-the-Belt Neurology: Bladder, Bowel & Sexual Dysfunction
      Tamara Kaplan, MD
    • Q&A
    • Keynote: State-of-the-Art Treatment of ALS
      James D. Berry, MD, MPH
    • Q&A with Course Directors
      Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD

    Thursday, October 12, 2023

    DAY FOUR

    • Neurological Complications of Checkpoint Inhibition and Other Immunotherapies in Cancer Patients
      Isabel Arrillaga-Romany, MD, PhD
    • Q&A
    • Evolving Uses of Imaging in Neurology
      Joshua P. Klein, MD, PhD
    • Q&A
    • Optimizing Your Approach to Treating Multiple Sclerosis
      Eric C. Klawiter, MD
    • Q&A
    • Modern Diagnosis and Treatment of Cerebellar Ataxias
      Jeremy D. Schmahmann, MD
    • Q&A
    • Update on Diagnosing and Treating Eye Movement Disorders
      Robert M. Mallery, MD
    • Q&A
    • Neurology of Skull Base Lesions
      Bart K. Chwalisz, MD
    • Q&A
    • Treating Neurological Cancer
      Eudocia Quant Lee, MD, MPH
    • Q&A
    • Alcohol Associated Neurological Disorders
      Michael E. Charness, MD
    • Q&A with Course Directors
      Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD

    Friday, October 13, 2023

    DAY FIVE

    • Neuropathy and Neuromuscular Junction: Cases Offering Clinical Pearls
      Christopher T. Doughty, MD
    • Q&A
    • Updates in the Neurologic Impact of COVID
      Giovanna S. Manzano, MD
    • Q&A
    • Contemporary Issues in Women's Neurology
      Mary Angela O'Neal, MD
    • Q&A
    • Neuroprognotication, Coma and Recovery
      Michael J. Young, MD
    • Q&A
    • Unusual and Difficult Cases of Headache-Diagnostic Challenges
      Brian E. McGeeney, MD, MPH, MBA
    • Q&A
    • Delivering the Best Care for Neck and Back Pain
      Shamik Bhattacharyya, MD
    • Q&A
    • New Treatment Options for Migraine
      Elizabeth W. Loder, MD, MPH
    • Q&A
    • Treating Headache with Integrative Therapies
      Carolyn A. Bernstein, MD
    • Lessons in Global Neurology
      Farrah J. Mateen, MD, PhD
    • Q&A with Course Directors
      Sashank Prasad, MD; Tamara B. Kaplan, MD; Isabel Arrillaga-Romany, MD, PhD

- Orders under 45$ will have a shipping charge of a flat rate of 15$.

-Orders over 45$ will have Free Shipping.

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.

Testimonials

★★★★★


“I find the taste of Moringa tea to be very refreshing and it definitely gives me a feeling of ‘wellness’. I appreciate the ethics of the company. Am looking forward to trying the cream”

Elain
★★★★★


”I love knowing that everything is 100% chemical-free and tested in Canada. I also respect the sustainable farming approach that supports both Canada and Ethiopia.”

Alycia
★★★★★

Since I drink Moringa Tea I feel so much better. My mouth was always so dry but since I drink this tea I have so much saliva I drool.

I cannot believe how much it has helped me with my breathing. I love it. I even eat all the leaves - Thank you for introducing me to this herbal tea. I'm 85 years old.

Richard Dorge
Winnipeg, MB

Recently viewed